Evidence map›Paper›PMID 7545385›Full record

ArticleArchives of microbiology1995

Involvement of transglutaminase in the formation of covalent cross-links in the cell wall of Candida albicans.

J Ruiz-Herrera, M Iranzo, M V Elorza, R Sentandreu, S Mormeneo

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Promising immunotherapeutic targets for treating candidiasis.Frontiers in cellular and infection microbiology · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. TheThe Journal of biological chemistry · 2018
    Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

J Ruiz-HerreraDepartamentos de Ingeniería Genética y Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Irapuato, Irapuato, Gto., Mexico
M Iranzo
M V Elorza
R Sentandreu
S Mormeneo
Universitat de València · ESInstituto Tecnológico Superior de Irapuato · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activity of the enzyme glutaminyl-peptide--glutamylyl-transferase (EC 2.3.2.13; transglutaminase), which forms the interpeptidic cross-link N epsilon-(gamma-glutamic)-lysine, was demonstrated in cell-free extracts obtained from both the yeast like and mycelial forms of Candida albicans. Higher levels of enzymatic activity were observed in the cell wall fraction, whereas the cytosol contained only trace amounts of activity. Cystamine, a highly specific inhibitor of the enzyme, was used to analyze a possible role of transglutaminase in the organization of the cell wall structure of the fungus. Cystamine delayed protoplast regeneration and inhibited the yeast-to-mycelium transition and the incorporation of proteins into the cell wall. The incorporation of covalently bound high-molecular-weight proteins into the wall was sensitive to cystamine. Proteic epitopes recognized by two monoclonal antibodies, one of which is specific for the mycelial walls of the fungus, were also sensitive to cystamine. These data suggest that transglutaminase may be involved in the formation of covalent bonds between different cell wall proteins during the final assembly of the mature cell wall.

Indexed as

Antibodies, FungalAntibodies, MonoclonalAntigens, FungalCandida albicansCell WallCystamineEpitopesFungal ProteinsMolecular WeightProtoplastsTransglutaminasesAntibodies, FungalAntibodies, MonoclonalAntigens, FungalCystamineEpitopesFungal ProteinsTransglutaminases

Identifiers

PMID7545385
OpenAlexW2069844992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.